The Influential Work of JeanMarie Guenot

 

 

In the last decade, Amphivena Therapeutics, a company based out of San Francisco, has done groundbreaking research in finding ways to eradicate blood cancers. President and CEO of Amphivena Therapeutics, JeanMarie Guenot, is the reason for its success. She provides leadership and experience that helps guide Amphivena Therapeutics to research and discover ways to combat blood cancers, to restore blood formation, and circulation.

 

Looking at JeanMarie Guenot’s success with Amphivena Therapeutics addresses how much she has accomplished in her career. Part of her success stems from having 20 years of experience in the pharmaceutical and biotechnology industry. Furthermore, she has experienced in pharmaceutical R&D, corporate & commercial development, as well as other business sectors, which is mentioned on Amphivena.com. Prior to her involvement with Amphivena, she founded and built SKS Ocular, a start-up ophthalmic company incubator. CrunchBase reports that during Jeanmarie’s tenure with SKS Ocular, she became involved in medical treatments that involved macular degeneration, inflammations, and other medical issues. Her career continued to blossom when she became a business advisor for Hoffmann-La Roche in Basel and Shanghai, and she was Vice President of Corporate & Business Development at PDL BioPharma.

 

While her prior experience addresses some of her biggest accomplishments, she also has achieved a great deal more in the medical field. As a business consultant, she was able to lead a successful deal between PDL and Hoffmann La Roche. She has also served as president and vice president of Corporate and Business Development at PDL BioPharma, according to an online source. It is considered one of her greatest accomplishments.

 

After building a successful career with different organizations, she has continued to find success with what she has been able to accomplish in Amphivena Therapeutics. Currently, she and Amphivena are working on developing a first-in-class bi-functional anti-body therapy as a way to treat blood cancers, according to their website.

 

JeanMarie Guenot has accomplished a great deal throughout her career, specifically with what she done being a part of Amphivena Therapeutics. She has been recognized with various accolades for her accomplishments. It ultimately demonstrates how influential she has become. Learn more about Dr. Guenot and her mission on her website here: http://jeanmarieguenot.com/

 

Leave a Reply

Your email address will not be published. Required fields are marked *